相关实验视频
Updated: Feb 26, 2026

05:34
Sexual Crosses with the Mucoromycete Phycomyces blakesleeanus
Published on: June 6, 2025
640
Aspergillus nidulans转录因子SclB控制了从植物性向无性发育的过渡
Emmanouil Bastakis1, Rebekka Harting1, Alexandra Scheel1
1Department of Molecular Microbiology and Genetics, Institute for Microbiology and Genetics, University of Göttingen, Göttingen, Germany.
mBio
|February 25, 2026
概括
通过控制关键的发育基因,SclB蛋白调节真菌中的无性繁殖. 这项研究揭示了SclB如何调节Aspergillus nidulans从植物生长到无性生长的过渡.
科学领域:
- 菌类学 菌类学是指菌类学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 丝状真菌中无性繁殖对于快速殖民和分散至关重要.
- 团蛋白SclB是已知的无性生长和二次新陈代谢的调节者.
- 了解SclB的作用是控制真菌发育的关键.
研究的目的:
- 阐明SclB控制Aspergillus nidulans从植物生长转变为无性生长的机制.
- 在条件化过程中确定SclB的直接目标.
- 调查各种真菌物种中SclB功能的保护.
主要方法:
- 在两个不同的生长条件下对Aspergillus nidulans进行比较分析.
- 染色体免疫沉与下一代测序 (ChIP-seq) 相结合.
- 转录基因分析 (RNA-seq).
主要成果:
- SclB 直接控制关键条件调节者的表达,包括 BrlA,VelB 和 PpoC.
- 在SclB目标促进体中,发现了一种新的9个基对DNA基因,即SclB反应元件.
- 来自Verticillium dahliae的同源蛋白Scl2部分补充了阿斯伯吉卢斯尼杜兰斯的asclB缺乏.
结论:
- SclB 是一个主调节器,协调了阿斯伯吉路斯尼杜兰斯 (Aspergillus nidulans) 转向无性繁殖的过程.
- 在SclB的作用中,SclB通过直接控制菌形成所必需的基因的转录来起作用.
- 这些发现提供了关于真菌发育调节的见解,以及真菌控制策略的潜在目标.
相关概念视频
Gene Regulation During Sporulation
551
Sporulation is a complex developmental process that allows certain Gram-positive bacteria, such as Bacillus subtilis and Clostridium species, to survive extreme environmental conditions. This process is tightly regulated by a series of signaling cascades and transcriptional controls, ensuring the formation of a highly resistant endospore.Sporulation is triggered by unfavorable conditions, such as nutrient depletion, and is governed by a phosphorelay system. One of the sensor kinases, such as...
551
Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
Master Transcription Regulators
7.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
Zygotic Development And Stem Cell Formation
7.0K
The development of all multicellular organisms starts with the fusion of haploid cells called sperm and egg to form a diploid zygote. A zygote is a totipotent cell that can develop into a complete organism. The zygote undergoes cell division or cleavage to form an 8-cell mass. Until this stage, the cells are spherical, loosely attached, and remain totipotent. Totipotent cells are capable of developing both the embryonic and the extraembryonic tissues. However, as they continue to divide, they...
7.0K
Morphogenesis
30.6K
Plant morphogenesis—the development of a plant’s form and structure—involves several overlapping developmental processes, including growth and cell differentiation. Precursor cells differentiate into specific cell types, which are organized into the tissues and organ systems that make up the functional plant.
30.6K
Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K

